These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 13356579)

  • 1. Unusual neurological complications due to largactil.
    FALLIK A; TREVES J
    Confin Neurol; 1956; 16(2-3):81-6. PubMed ID: 13356579
    [No Abstract]   [Full Text] [Related]  

  • 2. [Psychiatric experiences with megaphen (largactil) and the Rauwolfia alkaloid serpasil with special reference to Parkinson's psychomotor syndrome].
    HAASE HJ
    Nervenarzt; 1955 Dec; 26(12):507-10. PubMed ID: 13297074
    [No Abstract]   [Full Text] [Related]  

  • 3. Parkinsonian reactions following chlorpromazine and reserpine; similar reactions in the same patients.
    MAY RH; VOEGELE GE
    AMA Arch Neurol Psychiatry; 1956 May; 75(5):522-4. PubMed ID: 13312735
    [No Abstract]   [Full Text] [Related]  

  • 4. [Definition and mode of action of the psychomotor Parkinson syndrome therapeutically induced by serpasil and largactil].
    HAASE HJ
    Monatsschr Psychiatr Neurol; 1956 Apr; 131(4):201-14. PubMed ID: 13334283
    [No Abstract]   [Full Text] [Related]  

  • 5. [Parkinson like manifestations produced by medicamentation].
    FLUGEL F
    Med Klin; 1955 Apr; 50(15):634-5. PubMed ID: 14383166
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments on the biological and psychopathological basis of individual variation in chlorpromazine therapy.
    FREYHAN FA
    Encephale; 1956; 45(4):913-9. PubMed ID: 13384321
    [No Abstract]   [Full Text] [Related]  

  • 7. Abdominal pain following use of chlorpromazine.
    BARTHOLOMEW LG; CAIN JC
    J Am Med Assoc; 1957 Mar; 163(9):733-4. PubMed ID: 13405728
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlorpromazine (thorazine) hepatitis: report of three cases.
    GOLD H; ROSENBERG F; CAMPBELL W
    Ann Intern Med; 1955 Oct; 43(4):745-57. PubMed ID: 13259332
    [No Abstract]   [Full Text] [Related]  

  • 9. Chlorpromazine hepatitis without clinical jaundice.
    BARTHOLOMEW LG; CAIN JC
    Proc Staff Meet Mayo Clin; 1956 Apr; 31(7):201-4. PubMed ID: 13310598
    [No Abstract]   [Full Text] [Related]  

  • 10. Chlorpromazine hepatitis treated with cortisone.
    CUTTS M
    Ann Intern Med; 1957 Jun; 46(6):1160-1. PubMed ID: 13435663
    [No Abstract]   [Full Text] [Related]  

  • 11. Chlorpromazine and iproniazid toxic hepatitis in the same patient.
    BERNSTEIN A; SIMON F
    AMA Arch Intern Med; 1959 Jun; 103(6):954-6. PubMed ID: 13648998
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neurological complications during imipramine therapy].
    POROT M; PASCALIS G
    Rev Otoneuroophtalmol; 1959; 31():486. PubMed ID: 14434233
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal toxic hepatitis following chlorpromazine therapy; report of a case with autopsy findings.
    RODIN AE; ROBERTSON DM
    AMA Arch Pathol; 1958 Aug; 66(2):170-5. PubMed ID: 13558828
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver damage and eosinophilia following chlorpromazine therapy; report of a case.
    HARTNETT BS
    Br Med J; 1955 Jun; 1(4928):1458-9. PubMed ID: 14378593
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypothesis on the mechanism of action of chlorpromazine (largactil) on the extrapyramidal manifestations of the parkinsonian syndrome].
    MEGGIO B; CATTANI F
    Gazz Med Ital; 1955 Oct; 114(10):235-7. PubMed ID: 13277694
    [No Abstract]   [Full Text] [Related]  

  • 16. [Multiple paralysis of the cranial nerves produced by neoplasms of the base of the cranium].
    CANELAS HM; JULIAO OF
    Arq Neuropsiquiatr; 1961 Sep; 19():185-219. PubMed ID: 13690403
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversibility of drug-induced parkinsonism.
    CAHAN RB; PARRISH DD
    Am J Psychiatry; 1960 May; 116():1022-3. PubMed ID: 13806781
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences and conclusions in regard to the use of hirepin. Part I].
    GOLDSCHMIDT D
    Ideggyogy Sz; 1960 Apr; 13():97-103. PubMed ID: 13850736
    [No Abstract]   [Full Text] [Related]  

  • 19. Theoretical considerations in parkinsonism induced by tranquilizing drugs.
    GUGGENHEIM P; COHEN L
    Dis Nerv Syst; 1959 Aug; 20():346-52. PubMed ID: 13830100
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychomotility and parkinsonism in treatment with neuroleptic drugs.
    FREYHAN FA
    AMA Arch Neurol Psychiatry; 1957 Nov; 78(5):465-72. PubMed ID: 13468837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.